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Abstract
Background: Human erythrocytes are terminally differentiated, anucleate cells long thought to lack RNAs. However,
previous studies have shown the persistence of many small-sized RNAs in erythrocytes. To comprehensively define
the erythrocyte transcriptome, we used high-throughput sequencing to identify both short (18–24 nt) and long
(>200 nt) RNAs in mature erythrocytes.
Results: Analysis of the short RNA transcriptome with miRDeep identified 287 known and 72 putative novel
microRNAs. Unexpectedly, we also uncover an extensive repertoire of long erythrocyte RNAs that encode many
proteins critical for erythrocyte differentiation and function. Additionally, the erythrocyte long RNA transcriptome
is significantly enriched in the erythroid progenitor transcriptome. Joint analysis of both short and long RNAs
identified several loci with co-expression of both microRNAs and long RNAs spanning microRNA precursor regions.
Within the miR-144/451 locus previously implicated in erythroid development, we observed unique co-expression
of several primate-specific noncoding RNAs, including a lncRNA, and miR-4732-5p/-3p. We show that miR-4732-3p
targets both SMAD2 and SMAD4, two critical components of the TGF-β pathway implicated in erythropoiesis.
Furthermore, miR-4732-3p represses SMAD2/4-dependent TGF-β signaling, thereby promoting cell proliferation
during erythroid differentiation.
Conclusions: Our study presents the most extensive profiling of erythrocyte RNAs to date, and describes
primate-specific interactions between the key modulator miR-4732-3p and TGF-β signaling during human
erythropoiesis.
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Background
Human erythrocytes provide gas transport throughout
the body and comprise the majority of cells in whole
blood. Human diseases related to red blood cells (RBCs)
or erythrocytes, such as anemia or malaria, affect hun-
dreds of millions of people worldwide and present huge
health concerns. Although we have gained a significant
understanding of how these diseases occur and many
treatment options are available, we still cannot explain
many aspects of these erythrocyte diseases. Since the
precise regulation of both coding and noncoding RNAs
is essential for erythrocyte development, these erythro-
cyte diseases are often accompanied by significant tran-
scriptome changes. During erythropoiesis, microRNAs
actively regulate proliferation and/or differentiation of
erythroid cells during physiological and pathological
adaptions [1]. Dysregulation of various other long and
short RNAs also leads to several disease states such as
ineffective erythropoiesis and anemias. Circulating eryth-
rocytes can be easily obtained by blood drawing. Accord-
ingly, a detailed analysis of the erythrocyte transcriptome
may provide an accessible window into the developmental
history and pathophysiology of erythrocytes. However,
such an analysis has been deemed impossible since
circulating erythrocytes were thought to lack any genetic
materials.
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During terminal maturation of erythrocytes, the nu-
cleus is extruded from progenitors, leading to anucleate
cells with no further RNA production. Therefore, mature
erythrocytes were once thought to lack RNAs and have
significantly lower signals from RNA-binding dyes such
as methylene blue. However, many studies have shown
erythrocytes do contain diverse and abundant small
RNA species [2], including noncoding RNAs Y1 and Y4
[3] as well as microRNAs [4, 5]. We have previously
shown that higher levels of miR-144 and miR-451 reflect
the hemolytic phenotype and malaria resistance of sickle
erythrocytes, respectively [6, 7]. Additionally, both miR-451
and miR-144 reside in a locus that is regulated by GATA-1,
are highly induced during erythroid differentiation, and are
critical to erythropoiesis [8]. Therefore, extensive profiling
of the RBC transcriptome is critical for an understanding
of erythrocyte biology. The RNA composition of erythro-
cytes may also change during long-term storage for future
blood transfusion [9].
However, previous transcriptomic analyses were lim-
ited to known erythrocyte microRNAs using microarrays
[4], or known microRNAs from mixed reticulocyte
(immature red blood cell) and erythrocyte populations
using sequencing [10]. In addition, it is not clear whether
erythrocytes also contain long (large-sized) RNAs that
may provide valuable insights into their development and
adaptations. With the recent advances in high-throughput
sequencing technologies, it is possible to perform RNA-
Seq to identify both known and unknown transcripts.
Here, we employed high-throughput sequencing to
characterize both short (small, 18–24 nt) and long
(large, > 200 nt) RNAs in human erythrocytes. For long
RNA profiling, we prepared RNA-Seq libraries using a
protocol that allows for identification of both polyadeny-
lated and non-polyadenylated RNAs. A total of 6843 tran-
scripts were expressed in all three analyzed erythrocyte
samples. While this number is far less than that of typical
nucleated cells, these analyses established a surprisingly
diverse RBC transcriptome. In parallel, short RNA se-
quencing libraries were prepared and the miRDeep pipe-
line was utilized to identify both known and putative
microRNAs. From these analyses, we identified in mature
erythrocytes an abundant, diverse set of microRNAs that
include both known and putative microRNAs. The joint
analysis of transcriptomes identified several loci with
expression of both long and short RNAs, suggesting their
coordinated regulation of expression or processing.
Furthermore, we performed a functional investigation of
the uncharacterized, primate-specific miR-4732-3p within
the miR-144/451 locus. MiR-4732-3p was predicted to
target both SMAD2 and SMAD4 [11], components of the
TGF-β pathway instrumental in fine-tuning proliferation
for efficient erythropoiesis [12]. We provide multiple lines
of experimental evidence to show that this microRNA
modulates TGF-β signaling by directly inhibiting SMAD2
and SMAD4 production, thus promoting proliferation
during human in vitro erythroid differentiation. Our study
is the first to comprehensively profile the erythrocyte
transcriptome, and reflects the utility of high-throughput
sequencing to identify critical modulators of human
development.
Results
Mature erythrocytes contain a diverse repertoire of
long RNAs
To extensively profile the complete transcriptome of
mature erythrocytes, we obtained highly purified eryth-
rocytes from healthy donors. As previously described
[13], blood samples were leukocyte-depleted, separated
using a density gradient, and CD71- mature erythrocytes
were magnetically-selected. The purity of the sample
was first verified by flow cytometric analysis of CD71
expression (Additional file 1: Figure S1A) and further
validated by the lack of leukocyte transcripts in the se-
quencing data (described later). We isolated total RNA,
including small-sized RNA, and constructed sequencing
libraries for both short (18–24 nt) and long (>200 nt)
RNAs from erythrocyte RNA samples. RNA from five in-
dividuals was used for erythrocyte short RNA-seq, and
RNA from three individuals was used for erythrocyte long
RNA-seq. Additionally, we isolated total RNA from
peripheral blood mononuclear cells (PBMCs) of three
individuals, and RNA from in vitro differentiating CD34+
erythroid progenitors (Day 8 of differentiation) of two
individuals. RNA from these nucleated erythroid and per-
ipheral blood mononuclear cells was isolated and used to
prepare strand-specific long RNA-seq libraries (detailed in
Methods) to compare with the transcriptome of erythro-
cytes. For long RNA-seq, hemoglobin and ribosomal
RNAs were first depleted from the sample, then barcoded
sequencing libraries were generated using random
primers. The sequencing libraries were pooled and 50 bp
paired-end sequencing was performed using the Illumina
HiSeq 2000 system. While we did not expect abundant
long RNAs in mature erythrocytes, sequencing unexpect-
edly identified a large, diverse repertoire of long RNAs in
erythrocytes. The 25 most abundant erythrocyte transcripts
(Table 1) and entire catalog (Additional file 2: Table S1) of
expressed long RNAs are described. To determine both
shared and unique aspects of the erythrocyte transcrip-
tome, we compared the erythrocyte transcriptome with
that of the PBMC and CD34+ erythroid progenitor
transcriptomes. Libraries from these nucleated cells were
prepared and run in parallel to that of the erythrocyte long
RNA sequencing samples. Using the same analytic
methodology and threshold (RPKM of ≥0.5), we found
that mature erythrocytes had far fewer expressed genes
(~8092 genes) than other nucleated blood cells such as
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PBMCs (~15743 genes) and erythroid progenitors (~15113
genes) (Fig. 1a). However, mature erythrocytes still have
thousands of transcripts that may provide unique insights
into erythroid biology.
To determine whether the long RNA erythrocyte tran-
scriptome reflects that of erythroid progenitors versus
PBMCs, we used GSEA (Gene Set Enrichment Analysis)
to determine the relative enrichment of the top 500
erythrocyte RNA transcripts in the day 8 erythroid pro-
genitor (D8) vs. PBMC samples. We observed a highly sig-
nificant enrichment of the top 500 erythrocyte transcripts
in the erythroid progenitor transcriptome (Fig. 1b).
Together, our data shows selective retention of many long
RNAs previously transcribed in nucleated erythrocyte pro-
genitors, consistent with the possibility the erythrocyte
RNAs were derived from erythroid precursors.
Recent studies have suggested that intron retention
and nonsense mediated decay may contribute to degrad-
ation of most transcripts during terminal differentiation
of granulocytes [14] and erythrocytes [15]. Therefore, we
analyzed the relative distribution of gene mapping
regions for erythrocyte long RNAs. On average, 93 % of
human erythrocyte long RNAs map to annotated exons
of coding and noncoding RNAs, far higher than that of
PBMCs (63 %) and erythroid progenitors (59 %) (Fig. 1c).
Therefore, compared with nucleated cells, relatively few
erythrocyte transcripts map to introns and intergenic
regions. This difference may reflect that nucleated cells,
when compared with anucleate erythrocytes, retain more
unprocessed RNAs in the nucleus. We also observed
slightly less coverage at the 3’ of erythrocyte transcripts,
compared to that of PBMC and erythroid progenitor
transcripts (Additional file 1: Figure S1B). Additionally,
when the top 500 highest expressed erythrocyte genes
were examined for GO (gene ontology) enrichment, we
found significant enrichment in pathways of cellular,
protein and macromolecule biosynthesis and metabo-
lisms, defense response, and protein ubiquitination
(Additional file 3: Table S2). These categories represent
both known and less appreciated functions critical for
erythrocyte activities, such as protein and macromol-
ecule synthesis for hemoglobin. Ubiquitin was originally
Table 1 Top 25 expressed long RNAs in erythrocytes
Rank Gene symbol Description Average relative expression
1 RNY1 RNA, Ro-associated Y1 847620
2 RNY4 RNA, Ro-associated Y4 215019
3 RPPH1 ribonuclease P RNA component H1 96625
4 RN7SK RNA, 7SK small nuclear 41008
5 UBA52 Ubiquitin A-52 residue ribosomal protein fusion product 1 15576
6 UBB Ubiquitin B 15389
7 BNIP3L BCL2/adenovirus E1B 19 kDa interacting protein 3-like 14362
8 SLC25A37 Solute carrier family 25 (mitochondrial iron transporter), member 37 12246
9 FTL ferritin, light polypeptide 10475
10 SNCA synuclein, alpha (non A4 component of amyloid precursor) 9959
11 TMEM56 transmembrane protein 56 8918
12 RPS12 ribosomal protein S12 7359
13 EPB41 erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) 6337
14 GYPC glycophorin C (Gerbich blood group) 5744
15 RN7SL4P RNA, 7SL, cytoplasmic 4, pseudogene 4953
16 AC079949.1 no description available 4543
17 PICALM Phosphatidylinositol binding clathrin assembly protein 4443
18 OAZ1 Ornithine decarboxylase antizyme 1 4330
19 ALAS2 5,-aminolevulinate synthase 2 4289
20 MBOAT2 Membrane bound O-acyltransferase domain containing 2 4250
21 RNY5 RNA, Ro-associated Y5 4027
22 FBXO7 F-box protein 7 4008
23 DNAJC6 DnaJ (Hsp40) homolog, subfamily C, member 6 3660
24 ADIPOR1 Adiponectin receptor 1 3574
25 SERF2 small EDRK-rich factor 2 3398
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identified in erythrocytes [16], and ubiquitination is es-
sential for enucleation during erythrocyte development
[17]. In addition, the enriched categories include GO of
G-protein coupled receptor (GPRC) protein signaling
pathways and defense response. Several studies have
highlighted the role of GPCRs in erythropoiesis [18, 19].
The enrichment of GO in defense response is unex-
pected and deserves investigation in future studies.
We also did not identify enrichment for inflammatory-
related gene signatures typically found in leukocytes
samples. None of the transcripts that encode leukocyte
marker such as CD20 (MS4A1) and different CD3
mRNAs, were expressed in any erythrocyte sample.
However, these transcripts were identified in the PBMC
transcriptomes. Together, this sequencing data validates
the successful depletion of leukocytes in the purified
erythrocyte samples.
Next, we examined the most abundant transcripts to
obtain insights into erythroid biology. Several of the




Fig. 1 Population characteristics of erythrocyte long RNAs. a Distribution of total number of expressed transcripts across indicated cell types.
A transcript was considered expressed if the RPKM value was ≥0.5. b GSEA analysis of the top 500 expressed erythrocyte transcripts in the ranked
expressed transcripts of the day 8 erythroid progenitor (D8) vs. PBMC samples. c Distribution of the genomic location for RNA-Seq reads. Locations
represent average number of reads for the three RBC, three PBMC, and two erythroid progenitor independent samples. Intronic reads are included
if <10 kb upstream of a transcription start site or <10 kb downstream of a transcription end site
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components of ribonucleoprotein complexes that repre-
sent persistent expression after terminal differentiation.
Many of the highest expressed genes in the erythrocyte
transcriptome also encode proteins highly relevant for
erythroid cell differentiation. For example, BNIP3L me-
diates mitochondrial clearance during reticulocyte ter-
minal differentiation [20]. Abundant SLC25A37 encodes
mitoferrin-1, an essential iron importer for the synthesis
of mitochondrial heme and iron-sulfur clusters in eryth-
roblasts [21], and FLT encodes the ferritin light chain, a
major component of intracellular iron storage [22]. An-
other top expressed gene, EPB41, constitutes the red cell
membrane cytoskeletal network, which plays a critical
role in erythrocyte shape and deformability [23].
In addition, several highly expressed erythrocyte tran-
scripts encode proteins with known functions previously
not associated with erythrocytes. For example, ADIPOR1
encodes the cellular receptor for adiponectin, a hormone
secreted by adipocytes that regulates fatty acid catabolism
and glucose levels. Interestingly, Japanese individuals with
anemia present significantly higher serum levels of adipo-
nectin that that of unaffected individuals, yet the function
of such an association remains unknown [24]. Highly
expressed TMEM56 (Transmembrane protein 56) and
OAZ1 (Ornithine Decarboxylase Antizyme 1) may also
have undiscovered roles in erythroid biology. The dis-
covery of these unexpected genes prompts future func-
tional investigation and may provide unexpected insights
into erythroid biology.
Mature erythrocytes contain a diverse repertoire of
known and putative microRNAs
In parallel with long RNAs, we also sequenced short
(18–24 nt) RNA species from five erythrocyte samples.
The short RNA libraries were constructed, pooled, and
then applied to the Illumina HiSeq 2000 to generate a
total of 97,144,661 reads. To discover small-sized RNAs
with microRNA-like characteristics, we employed the
miRDeep2 pipeline [25] (Fig. 2a), a widely used [26, 27]
probabilistic model algorithm based on canonical micro-
RNA precursor processing, and is therefore not limited
to previously annotated or highly conserved microRNAs.
We employed a cutoff for microRNAs based on a miR-
Deep score of ≥1, and ≥ 20 reads in at least one sample,
like that previously used [28]. In all, we identified 359
microRNAs. For the top 10 identified microRNAs,
similar percentages of reads were found in all five
erythrocyte samples (Fig. 2b), indicating reproducible ex-
pression of the most highly expressed microRNAs. All
expressed known microRNAs (Additional file 4: Table S3)
and all putative microRNAs (Additional file 5: Table S4)
are shown.
Several of the most abundant microRNAs in our data-
set were previously shown to be enriched in human
erythrocytes, thus validating our findings. For example,
the most abundant microRNA, miR-486-5p, accelerates
erythroid differentiation [29], and its overexpression was
associated with an erythroid-like subtype of megakaryo-
cytic leukemia [30]. MiR-451a and miR-144-3p are both
GATA-1-responsive microRNAs upregulated during
erythroid differentiation and play important roles in the
anti-stress capacity of erythrocytes [7, 8, 31–34]. Add-
itionally, miR-16, miR-92a, and the let-7 family of micro-
RNAs are all among the most abundant erythrocyte
microRNAs from previous studies [4, 35, 36]. Importantly,
high plasma levels of miR-486-5p, miR-92a, miR-16 and
miR-451a are associated with increased red cell hemolysis
in human plasma samples, consistent with their high
abundance in erythrocytes [37, 38]. Hence, our sequencing
data identified a large number of erythrocyte microRNAs.
While most of these microRNAs were previously associ-
ated with erythrocytes, several abundant microRNAs, such
as miR-182-5p, have not been previously associated with
erythroid cells.
The putative microRNAs identified by miRDeep were
further manually annotated and curated using both the
UCSC genome browser (hg38) and miRBase (v.21).
These analyses lead to 72 putative unannotated micro-
RNAs, and selected microRNA sequences that met
criteria for putative microRNAs are shown (Additional
file 1: Figure S2). We then determined the relative gen-
omic location and sequence conservation for both
known and putative erythrocyte microRNAs. The major-
ity of both known (91 %) and putative (81 %) micro-
RNAs mapped to intergenic or intronic regions, with
few microRNAs mapped to coding, untranslated, or long
ncRNA regions (Fig. 2c). These results indicate that
overall, newly identified putative erythrocyte microRNAs
reside in similar genomic regions to that of known
microRNAs. We also examined the evolutionary conser-
vation of both known and putative microRNAs across
six species (human, chimp, rhesus monkey, dog, mouse,
and zebrafish) by the number of species in which each full,
mature microRNA sequence was found (Fig. 2d). Known
microRNAs were identified in more species (4–6 species)
than putative microRNAs (1–3 species), and were there-
fore more conserved. Additionally, most putative micro-
RNA sequences (99 %) were only identified in primates,
while far fewer known microRNAs were only identified
primates (42 %). This disparity highlights the utility of
miRDeep to identify putative microRNAs that are mostly
primate-specific.
Joint analysis of erythrocyte long and short RNA
transcriptomes reveals novel elements within the
miR-144/451 locus
Next, we performed a joint analysis of the long and short
RNA erythrocyte transcriptomes. To determine whether
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erythrocyte microRNAs may post-transcriptionally regu-
late erythrocyte mRNAs, we assessed whether these
microRNAs may contribute to selective enrichment or
depletion of erythrocyte mRNAs. GSEA was used to
evaluate the potential enrichment and depletion of the
predicated target mRNAs for the top six expressed
erythrocyte microRNAs: miR-486-5p, miR-92-3p, miR-16-
5p, let-7a/f, and miR-451 in erythrocyte mRNAs, com-
pared to that of PBMC mRNAs. We observed that the
target mRNAs of these top expressed miRNAs were not
significantly enriched or depleted in the erythrocyte
mRNA dataset (Additional file 1: Figure S3).
Next, we identified long and short RNAs that map to
adjacent regions. Several long RNA transcripts that
spanned different annotated pre-microRNA loci were
identified (Additional file 6: Table S5). Together, we
observed three instances of co-expression for both
erythrocyte microRNAs and long RNAs spanning pre-
microRNA loci. There are two distinct patterns of co-
expression. In the first pattern, we observed co-expression
of both microRNAs and long RNA transcripts spanning
entire pre-microRNAs, including 5’ and 3’ flanking regions
in two loci (miR-6087 and miR-3687). In the second pat-
tern, we observed co-expression a long RNA spanning
only the 5’ portion of the miR-4732 pre-microRNA,
proximal to the miR-144/451 region; this lncRNA was
confirmed via RT-PCR (Additional file 1: Figure S4). We
focused on the co-expressed microRNAs and the long
RNA within the miR-144/451 locus for several reasons
(Fig. 3a). This locus has been widely implicated in erythro-
poiesis, and all RNAs in this locus contain a much higher
coverage (>50 reads) than that of RNAs in other co-
expression loci. Interestingly, when the sequencing reads
were mapped to the miR-144/451 locus, we found several
RNA reads mapped to distinct elements 5’ of pre-miR-144.
These RNAs include a ~250 nt lncRNA spanning the 5’
hairpin region of pre-miR-4732, as well as miR-4732-5p
and -3p (Fig. 3a).
Among the newly identified erythrocyte RNAs, we inves-
tigated the functional role of miR-4732-3p for several rea-
sons. First, both miR-4732-5p and -3p are previously
uncharacterized. Second, miR-4732-3p is much more
highly expressed than miR-4732-5p. Additionally, proximal
microRNAs miR-451a and miR-144-3p are significantly
induced during erythroid differentiation [8]. We used
real-time PCR to determine the expression dynamics
of miR-4732-3p and other erythrocyte microRNAs at dif-
ferent time points during in vitro differentiation of CD34+
erythroid progenitors (Fig. 3b). Similar to miR-451a and
miR-144-3p [8], both miR-144-5p and miR-4732-3p were
also upregulated during erythropoiesis (Fig. 3b). However,
miR-4732-5p levels were less dramatically upregulated
during erythropoiesis. Additionally, miR-486-5p was
upregulated and miR-221 was downregulated during
differentiation, as previously described [29, 39] (Additional
file 1: Figure S5), indicating successful differentiation of our
in vitro erythroid culture. Upregulation of miR-4732-3p, as
well as its physical proximity to the miR-144/451 locus
suggests its similar regulation and functional role during
erythroid development.
MirDeep maps miR-4732 to a predicted pre-microRNA
canonical stem-loop folding structure with distinct 5p- and
3p- mature sequence reads (Fig. 3c), indicative of a bona
fide microRNA. Interestingly, miR-4732-3p is primate-
specific, with full seed sequence identical only among pri-
mates. Within non-primate species, it is poorly conserved,
with both seed and non-seed mismatches (Fig. 3d). In
contrast, miR-451a, miR-144-3p, and miR-144-5p are all
highly conserved among primate and non-primate species
(Additional file 1: Figure S6). Together, the significant
miRDeep score (1.9), predicted pre-microRNA structure,
and proximity to the miR-144/451 locus underscores
the authenticity and potential functional relevance of
miR-4732-3p.
MiR-4732-3p directly regulates SMAD2 and SMAD4
Using the microRNA target prediction tool Targetscan [11],
556 genes were predicted to be regulated by miR-4732-3p
(Additional file 7: Table S6). We performed a GATHER
analysis [40] to identify the related predicted target
pathways among the target genes. We identified signifi-
cant enrichment in TGF-β signaling, with literature net-
works and protein-binding networks for SMAD3 [40].
SMAD2 and SMAD4 are both predicted to be regulated
by miR-4732-3p, with conserved seed sequence binding
sites in most species. TGF-β family cytokines bind to
(See figure on previous page.)
Fig. 2 MicroRNA identification pipeline and microRNA population characteristics. a Deep sequencing of short RNAs from mature RBCs was performed
using the Illumina HiSeq technology. Raw sequences were mapped to the genome, filtered through miRDeep, and categorized. Identified microRNA
loci were cross-referenced with miRBase (v. 21) and UCSC Genome Browser (hg 38) to distinguish between candidate novel and known microRNAs.
b Relative percentages (log base 10) of read numbers for top 10 microRNAs among five different samples. Percentages are averages based on total
number of known, mature microRNA reads for each sample. c Relative percentage representation of genomic location for both known and putative
microRNAs. Listed genomic locations for mature microRNA sequences are relative to RefSeq annotated transcripts in UCSC genome browser (hg38).
For mature microRNA sequences spanning both introns and coding region, or UTR and coding regions of alternative transcripts, sequence is listed in
coding region. d Relative percentage representation of sequence conservation for both known and putative microRNAs. Conservation of mature
microRNA sequence indicates exact sequence alignment in listed number of species (from human, chimp, rhesus monkey, dog, mouse, and zebrafish),
allowing for up to one base mismatch outside of the microRNA seed sequence (nucleotides 2–8), and no mismatches within the seed sequence
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associated membrane receptors, promoting receptor-
mediated phosphorylation of SMAD2 and SMAD3 to
associate with SMAD4 [12]. This activated SMAD2/3
complex binds to competing effectors SMAD4 or TIFγ to
fine-tune a balance between erythroid differentiation and
proliferation [41]. TGF-β activates the expression of sev-
eral SMAD4 target genes, including pai-1, p21, bim, and
bax [42, 43], shown to reduce cell viability and prolifera-
tion. For example, PAI-1, Bim, and Bax act as activators of
apoptosis and trigger cell death [44, 45]. In addition, p21
is a potent cell cycle inhibitor that binds to and inhibits
the activity of cyclin-CDK2, −CDK1, and -CDK4/6 com-
plexes [46]. The induction of these genes by TGF-β is con-
sistent with ability of TGF-β to inhibit proliferation and
increase cell death during erythropoiesis [47]. Inhibition
of SMAD2 or SMAD4 results in increased erythroid cell
proliferation [43, 48–51], but their effects on differenti-
ation are inconsistent. However, much remains unknown
about the upstream signals that coordinate the regulation
of these factors.
Based on these predictions and biological relevance,
we investigated the potential of miR-4732-3p to regulate
SMAD2 and SMAD4 (Fig. 4a). To test whether both of
these predicted targets contain bona fide repressive
elements, portions of 3’UTR of SMAD2 and SMAD4,
including the predicted target sites, were cloned into a
dual luciferase reporter. As shown, transfection with a
miR-4732-3p mimic significantly repressed normalized
Renilla 3’ UTR reporter activities of both SMAD2 and
SMAD4 in K562s, indicating the ability of miR-4732-3p
to regulate SMAD2/4 (Fig. 4b). To determine whether
endogenous miR-4732-3p repression would affect re-
porter expression, we inhibited miR-4732-3p with an
antisense oligonucleotide (ASO) and observed increased
relative Renilla reporter activities for both SMAD2 and
SMAD4 (Figs. 4c). This regulation occurs through the
predicted target miR-4732-3p binding sites, as mutation
of the respective target sequences in the 3’ UTR of
SMAD2 and 4 abrogated the endogenous microRNA-
mediated luciferase repression (Fig. 4d).
To understand the in vivo relevance of the regulatory re-
lationship between miR-4732-3p and SMAD2/SMAD4,
we determined whether miR-4732-3p inhibits the protein
levels of SMAD2 and SMAD4 (Fig. 4e-f). Transfection of
miR-4732-3p mimics in K562s reduced the protein levels
of both SMAD2 and SMAD4 (Fig. 4e), whereas inhibition
of miR-4732-3p increased the levels of SMAD2 and
SMAD4 protein (Fig. 4f). Thus, miR-4732-3p inhibits the
protein levels of both SMAD2 and SMAD4 through a
canonical microRNA-mediated regulation of 3’ UTRs.
miR-4732-3p regulates the TGF-β signaling cascade
Next, we assessed whether miR-4732-3p-mediated down-
regulation of SMAD2 and SMAD4 would affect TGF-β
signaling. TGF-β pathway activities were measured with a
Firefly luciferase TGF-β reporter construct driven by the
SMAD4-dependent CAGA element promoter (CAGA-luc)
[52]. Overexpression of miR-4732-3p in K562s resulted in
a significant reduction in relative reporter luciferase values
(Fig. 5a), demonstrating that miR-4732-3p suppresses
SMAD4-mediated transcription activities. Additionally,
we determined whether miR-4732-3p overexpression may
affect the level of SMAD4-dependent target genes,
such as pai-1, p21, bim, and bax [42, 43]. Overexpression
of miR-4732-3p significantly reduced the expression of all
these SMAD4-regulated genes (Fig. 5b).
Given the ability to suppress TGF-β signaling activity,
we hypothesized that miR-4732-3p may promote prolif-
eration by suppressing SMAD2 and SMAD4. Consistent
with this hypothesis, overexpression of miR-4732-3p in
differentiating CD34+ erythroid progenitors resulted in a
significant increase in total cell number (Fig. 5c). Fur-
thermore, the miR-4732-3p-mediated increase in cell
number was abolished by overexpression of SMAD2
and SMAD4 with cDNA constructs lacking miR-4732-
3p-responsive 3’UTRs (Fig. 5d). These results indicated
that miR-4732-3p increased erythroid cell number by
repressing the levels of SMAD2/4. Together, these data
are consistent with the possibility that miR-4732-3p
modulates TGF-β signaling to promote erythroid cell
survival and production during erythropoiesis.
Discussion
The discovery of abundant and diverse erythrocyte RNAs
opens the possibility of using these readily accessible
genetic materials as biomarkers to monitor various human
diseases and treatments that involve erythroid cells.
Sequencing allows for characterization and quantification
(See figure on previous page.)
Fig. 3 Genomic locations and expression dynamics of noncoding RNAs in the miR-144/451 locus. a Location, sequence read length, relative read
number, and vertebrate conservation of noncoding RNAs within the chromosome 17 miR-144/451 locus according to UCSC genome browser
(hg38). Solid lines indicate average read numbers, dotted lines represent highest and lowest standard deviations of read numbers across the
samples. The strand orientation of each noncoding RNA is indicated. b Expression of miR-144-5p, miR-4732-3p, and miR-4732-5p, during CD34+
erythroid differentiation using progenitors from three different individuals. Differentiation is listed from day 6 to day 16. U6 snRNA was used as a
loading control, with fold difference set relative to day 6. c Predicted folding structure for the miR-4732 pre-microRNA according to miRDeep, and
frequency of reads for mature microRNAs from one representative sample. The most prevalent mature read sequences for miR-4732-3p (red) and
miR-4732-5p (blue) are shown. d Sequence conservation of miR-4732-3p in listed species. Primates are listed adjacent to white box, non-primates listed
adjacent to black box. Seed sequence is boxed, and base mismatches with human miR-4732-3p are highlighted in red
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Fig. 4 (See legend on next page.)
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of not only annotated RNAs, but also novel mRNA
isoforms and noncoding RNAs. To the best of our know-
ledge, this is the first study that has employed high-
throughput sequencing to extensively profile both the long
and short RNA transcriptomes of human erythrocytes.
Here we focus on the primate-specific miR-4732-3p.
While this microRNA has been annotated in miRBase
(v.21), it has few reads (<10 per sample) in other datasets
and is uncharacterized. We found that miR-4732-3p is an
abundant erythrocyte microRNA within the erythroid-
enriched miR-144/451 locus. The identification of multiple
elements within the miR-144/451 cluster is not surprising,
as miR-144 and miR-451 are both highly expressed and
upregulated by GATA1 during erythrocyte development
[8]. Considering the proximity of these newly identified
noncoding RNAs to this locus, these RNAs are also likely
upregulated by GATA1. In addition, the lncRNA overlap-
ping miR-4732 may exist as a truncated form of a longer
RNA precursor which undergoes further processing for
production of the adjacent microRNAs within this locus.
Conversely, this lncRNA may simply be overlapping
within this region and not subject to coordinated pro-
cessing and regulation of adjacent noncoding RNAs. We
suggest further investigation into the potential RNA pro-
cessing mechanisms within this locus and functions of
these noncoding RNAs in erythroid cells.
The human erythrocyte is one of the most commonly
studied cell types, often used as a model system to
understand the general principles of molecular genetics,
biochemistry, membrane biology, and cell physiology. As
new RNA synthesis ends with nuclear extrusion, the ex-
pression level of any RNA species is determined mainly
by its turnover and decay [53]. The selective persistence
of particular RNAs in mature erythrocytes likely reflects
associated decay kinetics. Given the relative stability of
microRNAs, plasma microRNAs have been proposed as
valuable biomarkers. Several studies have suggested that
select plasma microRNAs are highly associated with
hemolysis. Many erythrocyte microRNAs, including
miR-92a and miR-486-5p, have been proposed as candi-
date plasma biomarkers for human diseases, yet red cell
lysis may contribute to this association, a concern that
has been raised previously [38].
As many microRNAs are highly conserved between
species [54], few primate-specific microRNAs have been
characterized [55, 56]. Primate-specific microRNAs are
generally associated with brain function, immune response,
or cancer progression. Our study is the first to identify the
role of a primate-specific microRNA in hematopoiesis.
Mir-4732-3p provides an additional layer of regulation for
primate erythropoiesis. Although mouse and other non-
primate models have provided valuable insight into human
physiology and disease, considerable divergence still exists
between human and mouse erythropoiesis [57]. Notably,
several groups have observed mild anemic phenotypes with
deletion of the abbreviated miR-144/451 locus in mice, yet
these studies did not take into account potential regulatory
factors flanking this site [31, 58]. Our study further illus-
trates the discrepancy between the regulatory mechanisms
of human and mouse erythropoiesis and supports investi-
gation specifically within human models to consider mech-
anisms that are not evolutionarily conserved.
In this study, we demonstrated that miR-4732-3p
inhibits TGF-β signaling to promote erythroid cell ex-
pansion during differentiation. As inhibition of SMAD2
and SMAD4 via RNAi-mediated mechanisms reflects
phenotypes previously documented [12, 43], this micro-
RNA modulates SMAD2 and SMAD4 activities to
achieve similar phenotypes. Dysregulation of the TGF-β
pathway has been implicated in several human erythroid
diseases. For example, overactivation of TGF-β signaling
has been extensively reported in β-thalassemia and MDS
(myelodysplastic syndrome), both characterized by inef-
fective erythropoiesis and anemia [50, 51, 59]. Though
other mRNA targets and phenotypes associated with
miR-4732-3p have yet to be elucidated, miR-4732-3p
represents a unique, endogenous TGF-β signaling in-
hibitor that promotes erythroid expansion, and has the
potential to be manipulated as a biomarker or novel
therapeutic for various anemia disorders.
Conclusions
Here we describe the first comprehensive, as well as joint
analysis of the human erythrocyte transcriptome. We
have made several important observations. First, in
addition to microRNAs, mature erythrocytes also contain
(See figure on previous page.)
Fig. 4 MiR-4732-3p directly regulates SMAD2 and SMAD4. a Alignment of miR-4732-3p and predicted target sites in the 3’ UTR of SMAD2 and SMAD4,
with mutated binding sites underlined. b Relative changes of reporter activities in K562s co-transfected with luciferase constructs and indicated microRNA
mimics. A portion the SMAD2 and the SMAD4 3’UTRs were cloned downstream of Renilla in separate psiCheck-2 vectors (n= 4) (*p< 0.05, **p < 0.01).
c Relative changes of reporter activities in K562s co-transfected with luciferase constructs and microRNA-blocking antisense oligonucleotides (ASOs)
(n= 4) (***p < 0.001). d Relative changes of reporter activities in K562s transfected with wild-type (WT) or mutated (MUT) SMAD2 or SMAD4 3’UTR
constructs (n= 4) (*p< 0.05). e Western blots of SMAD2 and SMAD4 protein expression 24 h after transfection of K562s with indicated microRNA mimics
or f microRNA ASOs. α-tubulin was used as a loading control for normalization. Protein desitometric values are listed. The fold change of expression for
each treatment group was first normalized to alpha tubulin input for that treatment, then ratio set relative to the control treatment
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long transcripts. Although smaller in number, erythrocyte
long transcripts are highly enriched in annotated
exons and largely encode proteins critical to erythrocyte
differentiation and functions. Therefore, quantitative
analysis of the erythrocyte transcriptome may reflect
erythrocyte development history and pathological adapta-
tions. Second, miRDeep identified 287 known and 72
putative novel microRNAs that include many microRNAs
that are either uncharacterized, or not previously associ-
ated with erythrocytes. Third, the joint analysis of long
and short transcripts identified a long noncoding RNA
and previously uncharacterized microRNAs in the
miR-144/451 locus. Finally, functional studies demonstrate
the primate-specific microRNA miR-4732-3p regulates the
TGF-β pathway during human erythropoiesis. This study
presents a novel post-transcriptional modulator of erythroid
Fig. 5 MiR-4732-3p regulates TGF-β signaling and promotes erythroid cell proliferation. a Relative changes of TGF-β reporter activities in K562 cells
co-transfected with luciferase constructs and microRNA mimics (n = 4) (**p < 0.01). Cells were transfected with microRNA mimic, SMAD4-responsive
Firefly construct, and a separate Renilla construct as a transfection control. b Relative mRNA levels of p21, PAI-1, Bax, and Bim 24 h after transfection of
K562s with microRNA mimics. Levels were determined using qPCR and normalized by GAPDH (n = 3) (*p < 0.05). c Total cell number of primary CD34
erythroid progenitors 48 and 72 h after equal numbers of cells were transfected with indicated microRNA mimics on day 8 of differentiation (n = 3)
(*p < 0.05). d Total cell number of primary CD34 erythroid progenitors 24 h after equal numbers of cells were transfected with indicated combinations
of microRNA mimics and overexpression constructs on day 8 of differentiation (n = 3) (*p < 0.05, **p < 0.01)
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development, and features a new transcriptomic data set
that provides new insights into erythroid biology.
Methods
Ethics, consent, and permissions
Blood samples were obtained from healthy adults via
venipuncture into vacutainer tubes (BD) using a protocol
(Pro00050295) approved by the Institutional Review
Board at Duke University Medical Center. Written,
informed consent was obtained from each donor.
Consent to publish
We have obtained consent to publish from the blood do-
nors to report individual donor data.
Cell sorting, purification, and RNA isolation
Blood was kept on ice after a single draw and was proc-
essed within 30 min of sample acquisition. For isolation
of erythrocytes from whole blood, blood samples were
processed as previously described [13]. Briefly, a portion
of whole blood was washed three times with PBS, centri-
fuged, and plasma and buffy coat removed. Leukocytes
were then depleted from the sample using a Purecell®
Leukocyte Reduction Filtration System. Reticulocytes
(immature red blood cells) were removed in the CD71
positive fraction using CD71 microbeads with the auto-
MACS® Separator (Miltenyi Biotec). For confirmation of
RBC purity after magnetic bead sorting, we used a
CD71-PE antibody (Miltenyi Biotec). Flow cytometry
was run on the BD FACSCantoII system using the
FACSDiva software. All additional flow cytometric ana-
lyses were performed using the FlowJo (v.7.6.4) software.
For isolation of PBMCs, a buffy coat was separated from
whole blood using a Ficoll-Paque (GE Healthcare) cen-
trifugation gradient, and remaining erythrocytes were
lysed using a red cell lysis buffer (Qiagen). Total RNA
was isolated using the mirVANA miRNA isolation kit
(Ambion).
RNA library preparation and sequence analysis
To prepare long RNA‐Seq libraries, 1 μg of purified total
input RNA was used with the TruSeq Stranded Total
RNA Sample Prep Kit with Ribo‐Zero Globin (Illumina).
A total of 100 ng of erythrocyte RNA was used to pre-
pare short RNA-seq libraries with the TruSeq Small
RNA Sample Prep Kit (Illumina). Total RNA-seq and
small RNA libraries were separately pooled and analyzed
using the Illumina HiSeq 2000 sequencing system. All
reads for total RNA-seq and small RNA-seq were sorted
based on quality, and raw sequences with removed 3’
linker sequences were obtained in FASTQ format. All
primary sequencing data are publicly available through the
Gene Expression Omnibus (GEO dataset GSE63703). For
long RNA-seq, the RNA-seq data was processed using the
TrimGalore toolkit to trim low quality bases and Illumina
sequencing adapters from the 3’ end of the reads. Only
pairs where both reads were 20 nt or longer were kept for
further analysis. Reads were mapped to the GRCh37r73
version of the human genome and transcriptome [60]
using the STAR RNA-seq alignment tool [61]. Reads were
kept for subsequent analysis if they mapped to a single
genomic location. RNA-Seq quality control, genomic pos-
ition summary statistics, and gene body coverage statistics
were generated with the RSeQC toolkit [62]. Gene expres-
sion in reads per million per kilobase (RPKM) value were
calculated using the cufflinks algorithm [63]. Genes that
had an RPKM value ≥0.5 in at least one sample were kept
for subsequent analysis. Short RNA-seq bioinformatic
analyses were performed using miRDeep2 and in house
Perl scripts, with methods similar to that previously de-
scribed [28]. Gene set enrichment analysis (GSEA) [64]
was computed using the top 500 genes expressed in RBCs
as the ‘gene set’, and the log2-fold-change of the D8/PBMC
samples as the input list to test for the enrichment of top
RBC expressing transcripts against those more specific to
D8 samples or the PBMC samples.
Cell culture
Mobilized Peripheral Blood CD34+ Cells (AllCells) were
grown in StemLine II media containing Glutamine
(Sigma) with 20 % BIT (StemCell Technologies) and 1 %
Penicillin/Streptomycin (Gibco). On Days 0–7, cells were
supplemented with growth factors IL-3 at 20 ng/mL
(Invitrogen), SCF at 50 ng/mL (Invitrogen), and Erythro-
poietin (Epo) at 3U/mL (Calbiochem). On days 8–12 cells
were only supplemented with IL-3 and Epo, and on days
13–16 cells were only supplemented with Epo. K562 cells
(ATCC) were maintained in RPMI containing glutamine
(Gibco), with 10 % Fetal Bovine Serum (Hyclone) and 1 %
Penicillin/Streptomycin (Gibco). All cell counts were per-
formed using a standard hemocytometer.
Transfection and luciferase assays
K562 and CD34 erythroid progenitor cells were trans-
fected with indicated plasmids and/or oligos using
Lipofectamine LTX (Invitrogen), HiPerfect (Qiagen), or
Attractene (Qiagen) reagents. For luciferase values, all
assays were performed in biological quadruplicate, and
Firefly and Renilla luciferase activities were measured
using the Dual-Glo Luciferase assay (Promega) and
luminometer (Tecan Infinate F200).
Western blot analysis
Cells were lysed with RIPA buffer supplemented with pro-
tease inhibitor cocktail (Sigma). Denaturing sample buffer
was added to protein samples, and samples were boiled
and resolved on Tris–HCl polyacrylamide gels. Resolved
proteins were then transferred onto polyvinylidene
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fluoride (PVDF) membranes (GE Healthcare) and probed
with the following primary antibodies: anti-rabbit Smad2
and anti-rabbit Smad4 (Cell Signaling Technology, Inc.),
and anti-mouse α-Tubulin (Sigma). The following se-
condary antibodies were used: goat anti-rabbit IgG-HRP
(Santa Cruz) and anti-mouse IgG-HRP (R&D Systems).
The western blot was visualized by enhanced chemilumin-
escence (Western Lightning-ECL Plus, PerkinElmer) and
exposed to film. Densitometric measurements were per-
formed with ImageJ software (http://rsb.info.nih.gov/ij/).
Quantitative PCR
To quantify relative microRNA expression, 200 ng of
total RNA was reverse-transcribed using the Taqman
microRNA reverse transcription kit (ABI). The resulting
cDNA was used to assess RNA expression by qPCR with
TaqMan microRNA real-time assays and Taqman uni-
versal master mix (ABI). Results were calculated using
the comparative CT method. We compared relative
levels of microRNAs with probes specific for the indi-
cated mature microRNA and normalized by U6 snRNA
expression. To quantify relative mRNA expression, RNA
was reverse-transcribed with SuperScript II following
the manufacturer’s protocol (Invitrogen). The resulting
cDNA was used to assess RNA expression by qPCR with
Power SYBRGreen PCR mix (ABI) and primers specific
for targets, with GAPDH for normalization. All qPCR
reactions were performed in technical triplicate using
the StepOnePlus system (ABI). Primers for qPCR were
previously described [42, 43].
Transfection of oligonucleotides
MiR-4732-3p microRNA mimic or non-targeting (NT)
microRNA mimic #1 (Dharmacon) were used for
microRNA overexpression. For microRNA inhibition, miR-
4732-3p antisense 2’-O-Methyl oligonucleotide (AMO) or
non-targeting (NT) antisense 2’-O-Methyl oligonucleotide
(Dharmacon) were used. For mRNA knockdown,
SMAD2 and SMAD4 SMARTpool siGENOME siRNAs
(Dharmacon) or Allstar negative control siRNA (Qiagen)
were used.
Plasmid constructs
For luciferase reporter constructs, a portion of the 3'
untranslated region (UTR) of SMAD2 and SMAD4 flank-
ing the predicted miR-4732-3p binding site was amplified
and cloned into the XhoI and NotI sites downstream of
Renilla luciferase in the psiCheck-2 vector (Promega). The
3’UTR mutated reporters were constructed using the
QuikChange II Site-Directed Mutagenesis kit (Stratagene,
CA) to mutate the predicted targets of the miR-4732-3p
seed sequence. Reporter construct PCR and mutagenesis
primers are listed (Additional file 8: Table S7). The
CAGA-luc SMAD-responsive Firefly construct was kindly
provided by the Dr. Gerard Blobe lab. An empty control
Renilla construct was obtained from Promega. The
SMAD4 cDNA overexpression construct was obtained
from Origene, and the SMAD2 cDNA (HsCD00001922)
overexpression construct [65] was obtained from DNASU.
Data analysis
All statistical analyses were performed using the GraphPad
Prism4 software package, and represent unpaired Student
t-tests. All graphs were drawn with either GraphPad
Prism4 or Microsoft Excel 2014 software packages.
Availability of supporting data
All additional sequencing data have been deposited in
the GEO (Gene Expression Omnibus) data repository
with the GEO series accession number GSE63703.
Additional files
Additional file 1: Figure S1. Confirmation of erythrocyte cell sorting
and long RNA read distribution. A) Distribution of cell fluorescence for
before sorting (presort), and erythrocyte (CD71-) and reticulocyte (CD71+)
populations after sorting in one sample. Cells were stained with the
CD71-PE antibody and fluorescence was recorded using flow cytometry.
B) Gene body coverage plot from transcription start site (TSS, 5’) to
transcription end site (TES, 3’) for listed samples. Figure S2. Sequences
and folding structures of two predicted putative microRNAs. Precursor
coordinates of the predicted microRNA precursors are listed. The most
prevalent read sequences for the putative mature microRNA and star
sequence from one representative sample are boxed in red and purple,
respectively. Figure S3. GSEA analysis of enrichment of the predicted
target RBC mRNAs vs. PBMC mRNAs for the top six expressed erythrocyte
microRNAs. Potential binding sites in mRNA 3’UTRs were identified using
Targetscan (release 7.0) [11]. Numbers of predicted target mRNAs for each
microRNA are shown. Note that let-7f and let-7a have the exact same
seed sequence, so their results are the same. Figure S4. RT-PCR validation
of lncRNA spanning miR-4732 precursor. A total of 500 ng of erythrocyte
RNA from one individual was reverse-transcribed using methods previously
described, except with the use of random hexamers for priming, instead of
oligo dTs. PCR-amplified lncRNA region is shown. GAPDH is expressed in
RBC samples and was used as a positive control. RT reactions without the
use of reverse transcriptase (−) were used as a negative control. Figure S5.
Regulation of miR-486-5p and miR-221 during erythroid differentiation.
Expression during CD34+ erythroid differentiation using progenitors from
three different individuals. Differentiation is listed from day 6 to day 16. U6
snRNA was used as a loading control, with fold difference set relative to
day 6. Figure S6. Conservation of miR-451a, miR-144-3p, and miR-144-5p in
the listed species. Primates are listed adjacent to white box, non-primates
listed adjacent to black box. Seed sequence is boxed, and base mismatches
are highlighted in red. (PDF 2445 kb)
Additional file 2: Table S1. Summary of all expressed long RNAs.
(XLSX 2170 kb)
Additional file 3: Table S2. GATHER gene ontology categorization of
top 500 expressed genes. (XLSX 70 kb)
Additional file 4: Table S3. Summary of known microRNAs. Number
of sequence reads was determined with either counts from known
microRNA sequence search (Seq search) or miRDeep output, using the
highest number of reads for that sequence. Listed genomic locations for
mature microRNA sequences are relative to RefSeq annotated transcripts
in UCSC genome browser (hg38). For mature microRNA sequences
spanning both introns and coding region, or UTR or coding of alternative
transcripts, sequence is listed in coding region. Conservation to human
(H), chimp (C), rhesus monkey (R), dog (D), mouse (M), and zebrafish (Z)
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are listed. Conservation of mature microRNA sequence indicates exact
sequence alignment in listed species, allowing for up to one base
mismatch outside of the microRNA seed sequence (nucleotides 2–8),
and no mismatches within the seed sequence. (XLSX 45 kb)
Additional file 5: Table S4. Summary of putative microRNAs. Genomic
location and conservation were determined with methods used for
Additional file 4: Table S3. (XLSX 17 kb)
Additional file 6: Table S5. Long RNA transcripts loci spanning
pre-microRNA regions. Loci are listed if 20 or greater long RNA-seq reads
max per sample spanned the indicated microRNA precursor region. Rank
(in average long RNA reads), chromosome and coordinates of precursor,
precursor ID, and maximum number of reads spanning precursors are
listed for each erythrocyte long RNA-seq sample. MicroRNAs are listed as
expressed if any microRNA mapping to the indicated precursor region
were present in 100 or greater reads for all short RNA-seq samples.
(XLSX 10 kb)
Additional file 7: Table S6. List of predicted targets for miR-4732-3p in
Targetscan. (XLSX 60 kb)
Additional file 8: Table S7. Primers used in this manuscript. (XLSX 10 kb)
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